Miller, Alexandra M.
Shah, Ronak H.
Pentsova, Elena I.
Pourmaleki, Maryam
Briggs, Samuel
Distefano, Natalie
Zheng, Youyun
Skakodub, Anna
Mehta, Smrutiben A.
Campos, Carl
Hsieh, Wan-Ying
Selcuklu, S. Duygu
Ling, Lilan
Meng, Fanli
Jing, Xiaohong
Samoila, Aliaksandra
Bale, Tejus A.
Tsui, Dana W. Y.
Grommes, Christian
Viale, Agnes
Souweidane, Mark M.
Tabar, Viviane
Brennan, Cameron W.
Reiner, Anne S.
Rosenblum, Marc
Panageas, Katherine S.
DeAngelis, Lisa M.
Young, Robert J.
Berger, Michael F.
Mellinghoff, Ingo K.
Article History
Received: 7 June 2018
Accepted: 17 December 2018
First Online: 23 January 2019
Competing interests
: E.I.P. reports advisory roles with AstraZeneca. V.T. is a founding investigator of Blue Rock Therapeutics. K.S.P. reports stock ownership in Pfizer. L.M.D. reports advisory roles for Sapience Therapeutics, Tocagen, BTG International, Roche, and Syndax. R.J.Y. reports research funding from Agios and advisory roles with Icon plc, NordicNeuroLab, and Puma Biotechnology. M.F.B. reports advisory roles with Roche and research funding from Illumina. I.K.M. reports research funding from General Electric, Amgen, and Lilly; advisory roles with Agios, Puma Biotechnology, and Debiopharm Group; and honoraria from Roche for a presentation.